Clinical Trials Directory

Trials / Completed

CompletedNCT01706224

Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals

Sero-prevalence of Pertussis Antibodies and Disease Awareness Among Healthcare Professionals in Spain

Status
Completed
Phase
Study type
Observational
Enrollment
757 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aims to determine the sero-prevalence of anti-pertussis antibodies among healthcare professionals at hospital centres in Spain.

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood sampleSamples will be tested to determine the presence of anti-pertussis antibodies.
OTHERData collectionElectronic Case Report Forms (eCRF)
OTHERData collectionQuestionnaires, active questioning.

Timeline

Start date
2012-11-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2012-10-15
Last updated
2014-01-13

Locations

3 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT01706224. Inclusion in this directory is not an endorsement.